CME Group Inc (CME) Given Consensus Rating of “Buy” by Brokerages

CME Group Inc (NASDAQ:CME) has received a consensus recommendation of “Buy” from the thirteen ratings firms that are covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $144.22.

A number of brokerages have recently commented on CME. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Citigroup increased their price target on CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, October 19th. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $164.00 price target for the company in a research note on Tuesday, January 2nd. Wells Fargo & Co increased their price target on CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research note on Wednesday, October 4th. Finally, Barclays increased their price target on CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research note on Tuesday, October 10th.

In related news, insider Sunil Cutinho sold 2,600 shares of the stock in a transaction on Friday, November 17th. The stock was sold at an average price of $139.57, for a total value of $362,882.00. Following the completion of the sale, the insider now directly owns 22,301 shares in the company, valued at $3,112,550.57. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Julie Holzrichter sold 12,920 shares of the stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $144.08, for a total value of $1,861,513.60. The disclosure for this sale can be found here. Insiders sold 42,603 shares of company stock valued at $6,250,726 over the last 90 days. 0.57% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of CME. PNC Financial Services Group Inc. increased its holdings in CME Group by 11.9% in the second quarter. PNC Financial Services Group Inc. now owns 86,143 shares of the financial services provider’s stock valued at $10,789,000 after purchasing an additional 9,142 shares during the period. Thrivent Financial For Lutherans grew its holdings in CME Group by 2.9% during the 2nd quarter. Thrivent Financial For Lutherans now owns 12,860 shares of the financial services provider’s stock worth $1,611,000 after acquiring an additional 360 shares during the period. Artisan Partners Limited Partnership acquired a new stake in CME Group during the 2nd quarter worth about $372,000. Public Sector Pension investment Board grew its holdings in CME Group by 21.7% during the 2nd quarter. Public Sector Pension investment Board now owns 93,810 shares of the financial services provider’s stock worth $11,749,000 after acquiring an additional 16,700 shares during the period. Finally, FIL Ltd grew its holdings in CME Group by 12.4% during the 2nd quarter. FIL Ltd now owns 928,526 shares of the financial services provider’s stock worth $116,288,000 after acquiring an additional 102,289 shares during the period. Institutional investors and hedge funds own 82.78% of the company’s stock.

CME Group (NASDAQ CME) traded up $2.07 during midday trading on Friday, reaching $154.28. The company’s stock had a trading volume of 1,558,652 shares, compared to its average volume of 1,350,000. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group has a 12-month low of $114.82 and a 12-month high of $155.29. The company has a market capitalization of $53,210.00, a PE ratio of 34.98, a PEG ratio of 2.05 and a beta of 0.72.

CME Group (NASDAQ:CME) last released its earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.03. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The firm had revenue of $890.80 million during the quarter, compared to analysts’ expectations of $890.22 million. During the same period in the prior year, the company earned $1.05 earnings per share. The company’s quarterly revenue was up 5.8% on a year-over-year basis. equities research analysts expect that CME Group will post 4.75 earnings per share for the current year.

The company also recently declared a dividend, which was paid on Tuesday, January 16th. Stockholders of record on Thursday, December 28th were paid a $3.50 dividend. This is a boost from CME Group’s previous dividend of $3.25. The ex-dividend date of this dividend was Wednesday, December 27th. CME Group’s dividend payout ratio is presently 59.86%.

ILLEGAL ACTIVITY NOTICE: “CME Group Inc (CME) Given Consensus Rating of “Buy” by Brokerages” was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://ledgergazette.com/2018/02/12/cme-group-inc-cme-given-consensus-rating-of-buy-by-brokerages.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply